ALK Positive
Patient-founded nonprofit for people with ALK-positive cancer and their care partners: peer groups, education, a second opinion program and research funding.
21 organizations · Showing 1–20
Patient-founded nonprofit for people with ALK-positive cancer and their care partners: peer groups, education, a second opinion program and research funding.
Tumor Portrait sequences your tumor's DNA and RNA and compares it with your normal DNA from saliva, a cheek swab or blood. Your doctor orders it. In October 2026 my cost was $4,500 out of pocket.
Caris tests tumor tissue or blood, reading the whole exome and transcriptome to look for changes that point to targeted drugs, immunotherapy or trials. Your oncologist orders it.
Echo Immune designs and makes personalized mRNA cancer vaccines for patients with solid tumors, handling sequencing, design, manufacturing, FDA paperwork and immune monitoring.
Patient-driven nonprofit community for people with EGFR-positive lung cancer and their caregivers: an active online group, education, summits and co-funded research.
Free research support for patients exploring diagnostics, treatments, and the people who can help.
Blood and tissue tests to find tumor biomarkers. Separate tests track residual disease and treatment response.
CancerVision compares tumor and normal DNA using whole-genome sequencing, with report support and trial matching.
JLF helps patients explore personalized cancer vaccines and coordinates the testing, design, manufacturing and doctors involved. Its program uses peptide vaccines.
Helps patients find cancer trials in China and coordinate the paperwork, travel and care-team handoffs.
National lung cancer nonprofit offering a free HELPLine with lung cancer navigators, one-on-one peer mentors, virtual meetups, online communities and the HOPE Summit; a major funder of lung cancer research.
Natera's Signatera is a personalized blood test, built from your tumor, that looks for traces of tumor DNA to check for remaining cancer, track treatment and catch a recurrence earlier. Your doctor orders it.
Tests treatment options on tumor cells to help explore drug combinations.
Explores biomarker-targeted imaging and radioligand approaches.
Develops blood-based tracking of a cancer’s presence, amount and changes over time.
Serova designs a personalized mRNA cancer vaccine from your tumor data and helps your doctor seek FDA permission to give it. The first review of your reports is free. The vaccine is experimental, and as of September 2026 no patient had received it.
Holon-S1 uses AI to infer spatial gene-expression patterns from digitized pathology slides. Research only.
Tests drugs on live tumor cells outside the body and returns a report to the ordering physician.
Deep tumor profiling across DNA, RNA and proteins, using existing fixed tissue.
Nonprofit for people diagnosed with lung cancer at 50 or younger and their families: free monthly Zoom groups, caregiver and grief groups, a resource directory and webinars.